Form 4 for BRTX BioRestorative Therapies, Inc.
Accepted 2025-10-20 00:00:00 ET · period of report 2025-10-06 · accession 0001021771-25-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-20 | 2025-10-06 | BRTX | Silva Francisco | VP of Research, Development, Dir | A - Grant | $1.60 | +11.7K | 171.4K | +7% | +$18.8K |
| D | 2025-10-20 | 2025-10-06 | BRTX | Silva Francisco | VP of Research, Development, Dir | A - Grant | $0.00 | +11.7K | 11.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Comon Stock | 2025-10-06 | A | A | 11,719 | $1.60 | 171,384 | D | — | — | |
| 2 | Derivative | Warrant | 2025-10-06 | A | A | 11,719 | $0.00 | 11,719 | D | $2.75 · 2026-04-08 to 2030-10-08 | 11,719 Common Stock |